A Serum-Stable supramolecular drug carrier for chemotherapeutics fabricated by a Peptide-Photosensitizer conjugate

J Colloid Interface Sci. 2023 Sep 15:646:959-969. doi: 10.1016/j.jcis.2023.05.131. Epub 2023 May 20.

Abstract

Supramolecular assemblies fabricated by peptide-photosensitizer conjugates have attracted increasing attentions in recent years as drug carriers for chemotherapeutics (CTs). However, these assemblies have been known to suffer from disintegration by serum components leading to off-target drug release, and thereby impairing antitumor effects and causing systemic toxicities. To address this problem, this study reports a nano-architectural self-assembly peptide-photosensitizer carrier (NSPC) fabricated by conjugating a phthalocyanine derivative (MCPZnPc) and ε-poly-l-lysine (EPL). By engineering the core and peripheral interactions, MCPZnPC-EPL (M-E) NSPC firmly encapsulated multiple CTs, creating CT@M-E NSPCs that were highly stable against disintegration in serum. More importantly, CT@M-E NSPCs exhibited controlled release of CTs in tumor tissues. The antitumor effects of CTs were further promoted by the synergism with the reactivated photodynamic effect. Furthermore, M-E NSPC-encapsulation optimized CTs' biodistribution reducing adverse effects in vivo. This study provides a serum-stable supramolecular drug delivery system with photodynamic effect, which is applicable for a broad-range of CTs to promote antitumor effects and ameliorate adverse effects.

Keywords: Chemotherapeutics; Drug delivery system; Peptide-photosensitizer conjugate; Serum stability; Supramolecular assemblies.

MeSH terms

  • Cell Line, Tumor
  • Drug Carriers
  • Drug Delivery Systems
  • Drug Liberation
  • Peptides / pharmacology
  • Photochemotherapy*
  • Photosensitizing Agents* / pharmacology
  • Photosensitizing Agents* / therapeutic use
  • Tissue Distribution

Substances

  • Photosensitizing Agents
  • Drug Carriers
  • Peptides